Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...
Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Fifty prostate cancer patients with elevated/increasing serum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback